Athletes Foot

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Athletes Foot
Generic name: TOLNAFTATE
Manufacturer: Imperial Feet B.V.
Product type: HUMAN OTC DRUG
SPL set ID: 1189c7d8-7c8f-ae01-e063-6294a90ac270
SPL ID: 31381b57-0c5e-cee7-e063-6294a90ae765
Version: 3
Effective date: 2025-10-21
Source export date: 2026-11-06
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/2233cb6af8c6b55a5e4a05449e8db0d2f259f3c061d5d001b654a8bea1cc1db2/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:52:45

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Athletes Foot	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		Imperial Feet B.V.	openfda.manufacturer_name
ndc	package	83837-002-01	openfda.package_ndc
ndc	product	83837-002	openfda.product_ndc
ndc11	package	83837000201	derived:openfda.package_ndc
rxcui		313423	openfda.rxcui
spl id		31381b57-0c5e-cee7-e063-6294a90ae765	id
spl set id		1189c7d8-7c8f-ae01-e063-6294a90ac270	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings . Do not use on children under 2 years of age unless directed by a doctor. . For external use only. . Avoid contact with the eyes. . If irritation occurs or there is no improvement within 4 weeks, discontinue use and consult a doctor. Ask a doctor If irritation occurs or there is no improvement within 4 weeks, discontinue use and consult a doctor. Stop Use If irritation occurs or there is no improvement within 4 weeks, discontinue use and consult a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.